Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai New Era Health Industry is a prominent Chinese state-owned enterprise specializing in the research, development, and manufacturing of health supplements, cosmetics, and household products. As a core subsidiary of the New Era Health Industry (Group) and part of the China Energy Conservation and Environmental Protection Group (CECEP), the company is best known for its Guozhen brand, particularly its pine pollen and bamboo leaf extract products. The company operates a large-scale industrial park in Yantai, Shandong, which serves as its primary production and R&D base. Its business model utilizes a massive direct selling network to distribute a wide range of natural health products across China and various international markets. The company integrates traditional Chinese medicine principles with modern biotechnology to develop wellness solutions focused on disease prevention and health maintenance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yantai New Era Health Industry.